0.39 USD
↘ 0.04 (10.20%)AT CLOSE (03:59 PM EST)
Lantern Pharma Inc. Common Stock (LTRN) is currently trading at $0.39. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (579.8%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, LTRN appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 16, 2026.